Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Disease Diagnostics Services In Usa
6 services found
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
Drive biomarker and drug discovery by unlocking novel insights on disease pathophysiology, biomarker expression, and drug response at the tissue and cellular ...
by:Exagen Inc. based inVista, CALIFORNIA (USA)
Autoimmune rheumatic disease pharmaceutical and diagnostic co-promotion, Autoimmune disease biomarker licensing, Complementary/Companion diagnostic development, Collaboration studies with novel Exagen ...
by:DxDiscovery, Inc. based inReno, NEVADA (USA)
Lyme disease is a devastating infection caused by the bacterium Borrelia burgdorferi (Bb). Ticks are a natural reservoir for Bb; the bacteria survive in salivary glands and are transmitted to humans during a bite event. Since Bb was isolated in the 1980s there has been an increasing awareness of the prevalence and spread of Lyme disease throughout the United ...
by:Lighthouse Lab Services based inCharlotte, NORTH CAROLINA (USA)
Independent Reference + Physician Office Labs. Looking into starting a laboratory testing business but not sure where to begin? Lighthouse Lab Services has the expertise to get your lab running in as little as 90 days. Whether you are building a lab from the ground up, adding new lines of testing, or simply adding testing capacity – we’re here to ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Aggregation or fragmentation of protein molecules primarily causes variations in molecular size, impacting their biological activity, stability, and their efficacy and safety as pharmaceuticals. In the development and production of biopharmaceuticals, even slight variations in molecular size can reduce drug efficacy or pose safety risks. Thus, precise detection and analysis of these variations ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
In eukaryotic cells, the 3' end of mRNA is often extended with a poly(A) tail, a sequence of purine nucleotides. The poly(A) tail is a long chain of adenosine nucleotides of variable length. This tail is crucial for mRNA stability, transport, and translation. The analysis of mRNA's 3' poly(A) tail is a vital technique in studying the polyadenylation at mRNA molecules' 3’ ends, with significant ...